Barely Significant
← all excerpts

Teduglutide for short bowel syndrome.

Aust Prescr · 2020 · PMC7186272 · PMID 32346219

1
hedged sentence
0.1700
closest p · 3.4× alpha
0.1700
boldest claim

The sentences

Although there were also more responders with the 0.1 mg/kg teduglutide dose compared to placebo, this effect did not reach statistical significance (25% vs 6%, p=0.17). 3 In a 28-week extension of the study, 68% (17/25) of patients who continued the 0.05 mg/kg daily dose had responded.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.